Paragon Genomics
The Director of R&D at Paragon Genomics leads assay design and development for next-generation sequencing products, focusing on molecular diagnostics and oncology applications. The role involves strategic leadership, innovation, oversight of assay development, and collaboration with multiple teams to translate scientific advances into market-ready products.
Headquarters
Fremont, California, United States
Company Size
11-50 employees
Founded
2015
Paragon Genomics is a life‑science company that develops targeted next‑generation sequencing (NGS) assays and library‑preparation technologies for research and clinical laboratories. Their core CleanPlex chemistry uses multiplex PCR–based targeted enrichment to enable compact, low‑input and FFPE‑compatible panels for oncology, infectious disease, hereditary conditions and microbial profiling. They offer off‑the‑shelf and custom panel design, kits, controls, and bioinformatics support to streamline sample-to‑answer workflows. Labs choose Paragon for high sensitivity and uniformity, fast turnaround, and flexible, scalable solutions for targeted sequencing projects.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Paragon Genomics.
94% above the average for this role
Principal Scientist, High-Throughput Sequencing
SAGA Diagnostics
R&D Specialist III
City of Duncan, Oklahoma
Senior Scientist R&D
Natera
Senior Genomic Scientist
Idexx Laboratories
Senior Scientist, Molecular Assay Development in R&D
Tempus AI
PhD-Level Research Scientist / Scientific Director
Nemours Estate